✉news ScienceBiology first seen 23 h ago, last 1 h ago, peak #1
Clonal Hematopoiesis Emerges as Biomarker for Longevity Medicine
Original: Clonal Hematopoiesis and Biological Aging: An Emerging Biomarker for Longevity Medicine
A medical article discusses clonal hematopoiesis, an age-related condition in which blood stem cells carry mutations, and its potential role as a biomarker of biological aging. The piece suggests it could become a useful marker in longevity medicine for assessing aging and disease risk, drawing attention from clinicians and researchers interested in aging biology.
Why now: Growing interest in longevity medicine and biological aging tests has put new biomarkers like clonal hematopoiesis in the spotlight.
clonal hematopoiesislongevity medicineCureus
Rank over time, top of the chart is #1. 30 snapshots from 23 h ago to 1 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/2744106